Nextech Crossover I GP S.a r.l. 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-24 4:15 pm Purchase |
2024-05-06 | 13G | Context Therapeutics Inc. CNTX |
Nextech Crossover I GP S.a r.l. | 7,419,355 9.900% |
7,419,355 (New Position) |
Filing |